Fluorescence PCR
-
Mycobacterium Tuberculosis DNA
It is suitable for qualitative detection of Mycobacterium tuberculosis DNA in human clinical sputum samples, and is suitable for auxiliary diagnosis of Mycobacterium tuberculosis infection.
-
14 High-Risk HPV with 16/18 Genotyping
The kit is used for qualitative fluorescence-based PCR detection of nucleic acid fragments specific to 14 human papillomavirus (HPV) types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) in cervical exfoliated cells in women, as well as for HPV 16/18 genotyping to help diagnose and treat HPV infection.
-
SARS-CoV-2 influenza A influenza B Nucleic Acid Combined
This kit is suitable for in vitro qualitative detection of SARS-CoV-2, influenza A and influenza B nucleic acid of the nasopharyngeal swab and oropharyngeal swab samples which of the people who were suspected infection of SARS-CoV-2, influenza A and influenza B.
-
SARS-CoV-2 Variants
This kit is intended to in vitro qualitative detection of novel coronavirus (SARS- CoV-2) in nasopharyngeal and oropharyngeal swab samples. RNA from SARS-CoV-2 is generally detectable in respiratory specimens during the acute phase of infection or asymptomatic people. It can be used further qualitative detection and differentiation of Alpha, Beta, Gamma, Delta and Omicron.
-
Real-time fluorescent RT-PCR kit for detecting SARS-CoV-2
This kit is intended to in vitro qualitatively detect the ORF1ab and N genes of novel coronavirus (SARS-CoV-2) in the nasopharyngeal swab and oropharyngeal swab collected from cases and clustered cases suspected with novel coronavirus-infected pneumonia and others required for the diagnosis or differential diagnosis of novel coronavirus infection.
